vs
Day One Biopharmaceuticals, Inc.（DAWN）与KINGSWAY FINANCIAL SERVICES INC（KFS）财务数据对比。点击上方公司名可切换其他公司
Day One Biopharmaceuticals, Inc.的季度营收约是KINGSWAY FINANCIAL SERVICES INC的1.0倍（$39.8M vs $38.6M），KINGSWAY FINANCIAL SERVICES INC净利率更高（-4.1% vs -49.6%，领先45.5%），KINGSWAY FINANCIAL SERVICES INC同比增速更快（30.1% vs -57.6%）
Day One Biopharmaceuticals是一家临床阶段生物制药公司，专注于为患有基因驱动型癌症的儿童及年轻成人患者开发精准靶向肿瘤疗法，推进创新候选药物研发，满足相关群体未被覆盖的医疗需求，主要在美国市场开展业务。
金斯威金融服务公司是一家专业金融控股企业，主要提供财产和意外伤害保险产品，包括个人车险、商业责任险、财产险等，核心市场覆盖北美地区，服务个人消费者、小微企业主及特定商业客户群体。
DAWN vs KFS — 直观对比
营收规模更大
DAWN
是对方的1.0倍
$38.6M
营收增速更快
KFS
高出87.6%
-57.6%
净利率更高
KFS
高出45.5%
-49.6%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $39.8M | $38.6M |
| 净利润 | $-19.7M | $-1.6M |
| 毛利率 | — | — |
| 营业利润率 | -60.9% | 0.8% |
| 净利率 | -49.6% | -4.1% |
| 营收同比 | -57.6% | 30.1% |
| 净利润同比 | -153.3% | -7.8% |
| 每股收益（稀释后） | $-0.19 | $-0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DAWNKFS
| Q4 25 | — | $38.6M | ||
| Q3 25 | $39.8M | $37.2M | ||
| Q2 25 | $33.9M | $30.9M | ||
| Q1 25 | $30.8M | $28.3M | ||
| Q4 24 | — | $29.6M | ||
| Q3 24 | $93.8M | $27.1M | ||
| Q2 24 | — | $26.4M | ||
| Q1 24 | $0 | $26.2M |
净利润DAWNKFS
| Q4 25 | — | $-1.6M | ||
| Q3 25 | $-19.7M | $-2.4M | ||
| Q2 25 | $-30.3M | $-3.2M | ||
| Q1 25 | $-36.0M | $-3.1M | ||
| Q4 24 | — | $-1.5M | ||
| Q3 24 | $37.0M | $-2.3M | ||
| Q2 24 | — | $-2.2M | ||
| Q1 24 | $-62.4M | $-2.3M |
营业利润率DAWNKFS
| Q4 25 | — | 0.8% | ||
| Q3 25 | -60.9% | -2.3% | ||
| Q2 25 | -103.1% | -3.6% | ||
| Q1 25 | -133.5% | -2.5% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | 31.6% | -2.5% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 2.9% |
净利率DAWNKFS
| Q4 25 | — | -4.1% | ||
| Q3 25 | -49.6% | -6.5% | ||
| Q2 25 | -89.4% | -10.2% | ||
| Q1 25 | -117.0% | -10.9% | ||
| Q4 24 | — | -5.0% | ||
| Q3 24 | 39.5% | -8.5% | ||
| Q2 24 | — | -8.3% | ||
| Q1 24 | — | -8.9% |
每股收益（稀释后）DAWNKFS
| Q4 25 | — | $-0.07 | ||
| Q3 25 | $-0.19 | $-0.10 | ||
| Q2 25 | $-0.29 | $-0.13 | ||
| Q1 25 | $-0.35 | $-0.13 | ||
| Q4 24 | — | $-0.08 | ||
| Q3 24 | $0.38 | $-0.10 | ||
| Q2 24 | — | $-0.08 | ||
| Q1 24 | $-0.72 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $451.6M | $8.5M |
| 总债务越低越好 | — | $70.7M |
| 股东权益账面价值 | $450.9M | $15.2M |
| 总资产 | $513.8M | $231.5M |
| 负债/权益比越低杠杆越低 | — | 4.66× |
8季度趋势，按日历期对齐
现金及短期投资DAWNKFS
| Q4 25 | — | $8.5M | ||
| Q3 25 | $451.6M | $9.5M | ||
| Q2 25 | $453.1M | $12.3M | ||
| Q1 25 | $473.0M | $6.5M | ||
| Q4 24 | — | $5.7M | ||
| Q3 24 | $558.4M | $6.7M | ||
| Q2 24 | — | $9.8M | ||
| Q1 24 | $317.9M | $12.3M |
总债务DAWNKFS
| Q4 25 | — | $70.7M | ||
| Q3 25 | — | $70.7M | ||
| Q2 25 | — | $58.3M | ||
| Q1 25 | — | $59.5M | ||
| Q4 24 | — | $57.5M | ||
| Q3 24 | — | $58.5M | ||
| Q2 24 | — | $47.3M | ||
| Q1 24 | — | $47.1M |
股东权益DAWNKFS
| Q4 25 | — | $15.2M | ||
| Q3 25 | $450.9M | $16.6M | ||
| Q2 25 | $460.8M | $17.4M | ||
| Q1 25 | $479.5M | $5.5M | ||
| Q4 24 | — | $8.4M | ||
| Q3 24 | $555.5M | $9.9M | ||
| Q2 24 | — | $20.7M | ||
| Q1 24 | $296.8M | $23.6M |
总资产DAWNKFS
| Q4 25 | — | $231.5M | ||
| Q3 25 | $513.8M | $235.1M | ||
| Q2 25 | $519.0M | $207.7M | ||
| Q1 25 | $534.4M | $192.1M | ||
| Q4 24 | — | $186.6M | ||
| Q3 24 | $600.8M | $191.1M | ||
| Q2 24 | — | $192.3M | ||
| Q1 24 | $326.6M | $198.0M |
负债/权益比DAWNKFS
| Q4 25 | — | 4.66× | ||
| Q3 25 | — | 4.25× | ||
| Q2 25 | — | 3.34× | ||
| Q1 25 | — | 10.91× | ||
| Q4 24 | — | 6.84× | ||
| Q3 24 | — | 5.88× | ||
| Q2 24 | — | 2.29× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.8M | $-3.0K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DAWNKFS
| Q4 25 | — | $-3.0K | ||
| Q3 25 | $-5.8M | $1.5M | ||
| Q2 25 | $-24.8M | $337.0K | ||
| Q1 25 | $-59.0M | $-1.8M | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | $50.8M | $368.0K | ||
| Q2 24 | — | $557.0K | ||
| Q1 24 | $-49.7M | $249.0K |
自由现金流DAWNKFS
| Q4 25 | — | — | ||
| Q3 25 | — | $1.3M | ||
| Q2 25 | $-24.8M | — | ||
| Q1 25 | $-59.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $50.0M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率DAWNKFS
| Q4 25 | — | — | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | -73.2% | — | ||
| Q1 25 | -192.8% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 53.4% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度DAWNKFS
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | 0.5% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.8% | 0.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率DAWNKFS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.37× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DAWN
| Products | $38.5M | 97% |
| License Agreement With Ipsen Pharma Sas | $1.3M | 3% |
KFS
| Other | $14.8M | 38% |
| Roundhouse Electric Equipment Co Inc | $9.7M | 25% |
| MLC Plumbing LLC | $5.7M | 15% |
| Systems Products International Incspi | $3.8M | 10% |
| Advanced Plumbing And Drain | $2.9M | 8% |
| Southside Plumbing | $1.7M | 4% |
